Warning for consumers
The U.S. Food and Drug Administration is warning consumers not to buy or use LUZE Fit Intensity, a product marketed for weight loss online and potentially through some retailers.
The warning was issued on September 15 after laboratory testing detected sibutramine in the product even though the substance was not listed on the label.
What the FDA found
Sibutramine was previously used in weight-loss medications but was removed from the U.S. market because of safety concerns.
According to the FDA, the substance can significantly increase blood pressure or heart rate in some people.
The risk is particularly concerning for people with a history of heart disease, heart failure, arrhythmias or stroke. The agency also warns that sibutramine can interact dangerously with other medications.
The product was marketed for weight loss
According to the FDA, LUZE Fit Intensity was found for sale on several websites, including the Shop platform.
The agency also warns that products marketed as dietary supplements or conventional foods can sometimes contain pharmaceutical ingredients that are not disclosed on their labels.
FDA advises consumers
The agency encourages consumers and healthcare professionals to report possible adverse reactions through its MedWatch program.
The FDA also notes that it cannot test every dietary supplement on the market. As a result, the absence of a product from its warning database does not automatically mean it has been tested or determined to be safe.
Source: U.S. Food and Drug Administration (FDA).
